Try Alerts Free   |   Login

RXRX Price Correlated With Financials For Recursion Pharmaceuticals

Free historical financial statements for Recursion Pharmaceuticals Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 5 quarters since 2021. Compare with RXRX stock chart to see long term trends.

RXRX Stock Compared to Quarterly

RXRX Income Statement

Revenue, Net:5333000
Revenue Per Share:0.0312
Cost of Goods & Services Sold:7799000
Selling, General & Admin Expense:21074000
Research & Development Expense:32441000
Total Operating Expenses:61314000
Operating Income:-55981000
Income Taxes:0
Net Income:-55979000
Earnings Per Share, Basic:-0.33
Shares Outstanding, Basic Avg:170690392

RXRX Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:2767000
Change in Accounts Receiveable:null
Net Cash from Operations:77388000
Net Cash from Operations Per Share:0.4534
Net Cash from Financing Activities:2084000
Property, Plant & Equipment Purchases:4342000
Net Cash from Investing Activities:143304000
Net Change in Cash & Equivalents:222776000

RXRX Balance Sheet

Cash and Cash Equivalents:518125000
Short-Term Investments:83214000
Accounts Receivable, Net:34000
Total Current Assets:619455000
Property, Plant & Equipment, Net:70704000
Total Assets:734319000
Accounts Payable:4162000
Total Short-Term Liabilities:85705000
Total Liabilities:240753000

Data imported from Recursion Pharmaceuticals Inc. SEC filings. Check original filings before making any investment decision.